Safety of Deferiprone in Patients with Myelodysplastic Syndromes: Results from the Deferiprone US Safety Registry and a Compassionate Use Program
Zeidan A, Fradette C, Rozova A, Temin N, Tricta F. Safety of Deferiprone in Patients with Myelodysplastic Syndromes: Results from the Deferiprone US Safety Registry and a Compassionate Use Program. Blood 2022, 140: 1115-1117. DOI: 10.1182/blood-2022-169074.Peer-Reviewed Original Research